Multiple Endocrine Neoplasia Type 1
A Pilot Study of Genetic Evaluation of Families with Endocrine Cancers in MEN1 syndrome
This study is being conducted to identify altered genetic factors that may exist and influence endocrine cancers in unrelated MEN1 families with different cancers. A grading system will be developed for endocrine cancers, including, pancreatic cancers, thymus gland cancers, parathyroid disease and MEN1 syndrome as low-risk and high-risk to improve screening and timing of surgery.
ClinicalTrials.gov Identifier: NCT01794676
Genetic Evaluation of Families With Endocrine Cancers (MEN1) Sponsor: Jersey Shore University Medical Center;
Collaborators: Princeton University Cancer Institute of New Jersey
Information provided by Alexander Shifrin, MD, FACS, FACE, Jersey Shore University Medical Center